Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances

Adarsh Kumar Yadav, Drashti Shah, Princy Desai, Utkarsha Kulkarni, Ashish Shah, Afzal Nagani, Paresh Patel, Divy Patel, Ashish Patel

Open source

DOI
10.2174/0113894501475706260831062144
Published
2026-09-14
Container
Current Drug Targets
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113894501475706260831062144,
  title = {Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances},
  author = {Adarsh Kumar Yadav and Drashti Shah and Princy Desai and Utkarsha Kulkarni and Ashish Shah and Afzal Nagani and Paresh Patel and Divy Patel and Ashish Patel},
  year = {2026},
  journal = {Current Drug Targets},
  doi = {10.2174/0113894501475706260831062144},
  url = {https://doi.org/10.2174/0113894501475706260831062144}
}

RIS

TY  - JOUR
TI  - Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances
AU  - Adarsh Kumar Yadav
AU  - Drashti Shah
AU  - Princy Desai
AU  - Utkarsha Kulkarni
AU  - Ashish Shah
AU  - Afzal Nagani
AU  - Paresh Patel
AU  - Divy Patel
AU  - Ashish Patel
PY  - 2026
JO  - Current Drug Targets
DO  - 10.2174/0113894501475706260831062144
UR  - https://doi.org/10.2174/0113894501475706260831062144
ER  - 

APA

Yadav, A. K., Shah, D., Desai, P., Kulkarni, U., Shah, A., Nagani, A., Patel, P., Patel, D., & Patel, A. (2026). Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances. Current Drug Targets. https://doi.org/10.2174/0113894501475706260831062144

Source records